PK

Pawan Kumar Shukla

Director Director DIN 09844239
DIN 09844239 First appointment Jan 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Pawan Kumar Shukla

Data last updated:

Pawan Kumar Shukla was a Director at Hindukush Bioproducts Private Limited (2023) and Director at Hindukush Pharmaceuticals Private Limited (2023). The companies operate in Pharma.

DIN 09844239
Primary Designation Director
Industry Pharma
First Appointment 02 Jan 2023

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Jan 20232016₹13.98 Cr (FY 2021)Active
Director04 Jan 20232021Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hindukush Bioproducts Private Limited
Hindukush Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pawan Kumar Shukla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pawan Kumar Shukla

Pawan Kumar Shukla was first appointed on 02 Jan 2023 as Director at Hindukush Bioproducts Private Limited.

Pawan Kumar Shukla held 2 earlier board appointments: Hindukush Bioproducts Private Limited (Director, 02 Jan 2023 to 15 Mar 2023); Hindukush Pharmaceuticals Private Limited (Director, 04 Jan 2023 to 15 Mar 2023).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available